1-4 of 4
Authors: Jianjun Gao
Save search
Sort by
Journal Article

A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC

PDF
Andrew W Hahn and others
The Oncologist, Volume 30, Issue 4, April 2025, oyaf053, https://doi.org/10.1093/oncolo/oyaf053
Published: 11 April 2025
Journal Article

Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma

PDF
Andrew C Johns and others
The Oncologist, Volume 29, Issue 7, July 2024, Pages 589–595, https://doi.org/10.1093/oncolo/oyae037
Published: 13 March 2024
Journal Article

Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy

PDF
Andrew W Hahn and others
The Oncologist, Volume 29, Issue 5, May 2024, Pages 392–399, https://doi.org/10.1093/oncolo/oyad302
Published: 30 November 2023
Journal Article

Nivolumab for the Treatment of Patients with Metastatic Non‐Clear Cell Renal Cell Carcinoma (nccRCC): A Single‐Institutional Experience and Literature Meta‐Analysis

PDF
Jad Chahoud and others
The Oncologist, Volume 25, Issue 3, March 2020, Pages 252–258, https://doi.org/10.1634/theoncologist.2019-0372
Published: 09 September 2019